Building on the June 10, 2021 New Atlantic Charter and the June 8, 2023 Atlantic Declaration on Economic Security, the U.S. National Security Council and the UK Cabinet Office announced a new Strategic Dialogue on Biological Security during a launch event today.
Underpinned by the UK Biological Security Strategy and the U.S. National Biodefense Strategy, this Strategic Dialogue reflects a shared ambition to bolster future heath and economic resilience against a growing and diverse spectrum of biological threats.
The Strategic Dialogue reaffirms both nations’ commitment to increase collaboration in the following ways:
- Develop a shared understanding of research and development (R&D) needs at the onset of new disease outbreaks, allowing for improved responsiveness by shaping global R&D efforts and supporting early technology assessments.
- Adopt a One Health approach to biosurveillance and biological threat detection, in support of international efforts to develop stronger and more interconnected global surveillance capabilities.
- Pursue the development of new tools and methodologies for microbial forensics and attribution.
- Promote responsible innovation in the biotechnology, health, and life sciences sectors, shaping global norms and standards on biosafety and biosecurity while simultaneously protecting burgeoning bio-economies.
- Facilitate the development of next-generation vaccines and therapeutics, in line with the 100-Days Mission vision supported by G7 leaders in Carbis Bay in 2021 and reaffirmed at the 2023 G7 Summit in Hiroshima.
- Strengthen coordination of efforts to counter biological threats, including developing joint measures to address Biological and Toxin Weapons Convention compliance.